Much is still unknown about the cancer process and how targeted therapies work on specific tumor vulnerabilities. Providers must closely follow evolving information, especially regarding adverse events
Solutions
![right arrow](/Ontada/images/icons/white-down-arrow.png?v=u3hjhmpNIp8etEtmS7upEeqmDPfsRubUgmP7L488NAo)
Life Sciences
![right arrow](/Ontada/images/icons/blue-right-arrow.png?v=4KFZ6vCSu6sqTp58mSQjR0Tul-I-DKOrhnC2bAf3LXY)
News & Events
![right arrow](/Ontada/images/icons/blue-right-arrow.png?v=4KFZ6vCSu6sqTp58mSQjR0Tul-I-DKOrhnC2bAf3LXY)
More